Business
PacBio’s Sequel IIe Selected by Prenetics to Build Personalized Genomics for Healthcare
Leading global genomics and diagnostic testing firm adds more comprehensive genetic information to its services MENLO PARK, Calif. and HONG KONG, Nov. 02,
About this update from Pacific Biosciences Of California, Inc.
[{"type":"text","content":"Leading global genomics and diagnostic testing firm adds more comprehensive genetic information to its services\nMENLO PARK, Calif. and HONG KONG, Nov. 02, 2021 (GLOBE NEWSWIRE) -- PacBio will be providing its high-quality, highly accurate sequencing platforms to Prenetics Group Limited, a leading global genomics and diagnostic testing company, as the firm adds more comprehensive genetic screening services including carrier screening and cancer-risk screening in Hong Kong, Southeast Asia and in the United Kingdom. “With the global success of CircleDNA for consumers, Circle Medical will be a physician-only product to specifically cater to a physician’s specialty. The partnership with PacBio enables us to expand the utility and opportunity of next generation sequencing technologies in both consumer and clinical settings.” said Danny Yeung, CEO of Prenetics. “PacBio’s SMRT HiFi sequencing technology is capable of providing additional genetic information in carrier screening and cancer risk screening, and we’re delighted to be bringing its advantages to our customers and patients,” said Dr. Senthil Sundaram MD, Chief Clinical Officer at Prenetics. PacBio’s technology will be a key component of Prenetics’ Circle Medical offering, a genetic test geared towards addressing the diagnostic needs of physicians and improving the accuracy of detecting mutations. Prenetics is also utilizing PacBio technology to apply epigenomics to both end-consumer oriented products, such as aging, skincare, and population health, as well as medically-oriented products such as colorectal cancer and liver cancer. “This partnership reflects the adaptability of PacBio SMRT sequencing technology when combined with the creativity of the world’s top researchers,” said Christian Henry, PacBio CEO. “Prenetics has shown strong business growth globally and we are excited to work with them closely on their next phase of growth with clinical genomics.” “The pairing of PacBio and Prenetics doesn’t just offer opportunities in consumer genetic testing, but shows how Sequel IIe can be used to make advances in biomedical research, clinical diagnostics and pharmaceutical solutions,” said Jonas Korlach, Chief Scientific Officer at PacBio. “We’re very excited to see how our HiFi technology is being used by scientists all around the world to advance science.” About PacBio Pacifi...